Skip to content

Latest commit

 

History

History
49 lines (41 loc) · 1.92 KB

File metadata and controls

49 lines (41 loc) · 1.92 KB
pmid 10608892
title Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.
authors
Sharp DA
Kratowicz SA
Sank MJ
George DL
journal J Biol Chem
year 1999
full_text_available false
doi 10.1074/jbc.274.53.38189

Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Authors: Sharp DA, Kratowicz SA, Sank MJ, George DL Journal: J Biol Chem (1999) DOI: 10.1074/jbc.274.53.38189

Abstract

  1. J Biol Chem. 1999 Dec 31;274(53):38189-96. doi: 10.1074/jbc.274.53.38189.

Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.

Sharp DA(1), Kratowicz SA, Sank MJ, George DL.

Author information: (1)Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6069, USA.

The MDM2 oncoprotein has transforming potential that can be activated by overexpression, and it represents a critical regulator of the p53 tumor suppressor protein. To identify other factors with a potential role in influencing the expression and/or function of MDM2, we utilized a yeast two-hybrid screening protocol. Here we report that MDM2 physically interacts with a structurally related protein termed MDMX. The results obtained in these studies provide evidence that C-terminal RING finger domains, contained within both of these proteins, play an important role in mediating the association between MDM2 and MDMX. The interaction of these proteins interferes with MDM2 degradation, leading to an increase in the steady-state levels of MDM2. MDMX also inhibits MDM2-mediated p53 degradation, with subsequent accumulation of p53. Taken together, these data indicate that MDMX has the potential to regulate the expression and function of the MDM2 oncoprotein.

DOI: 10.1074/jbc.274.53.38189 PMID: 10608892 [Indexed for MEDLINE]